Carolyn Bramante, MD, MPH

Assistant Professor, General Internal Medicine
University of Minnesota
Minneapolis, MN, United States

Dr. Bramante went to medical school at the University of Minnesota (UMN) and did residency in Internal Medicine and Pediatrics ("Med-Peds") at Johns Hopkins. After residency, she stayed at Hopkins for the General Internal Medicine (GIM) Fellowship from 2016 to 2018. This was a T32-funded fellowship focused on clinical research. She is board certified in Internal Medicine, Pediatrics, and Obesity Medicine.

After fellowship, Dr. Bramante returned to the UMN as a clinician investigator. She conducts remotely delivered clinical trials to improve health in children and adults with overweight and obesity. She has a specific interest in the interaction between adipose tissue and infectious diseases, i.e. Covid-19, throughout the life course.

Disclosure(s): No financial relationships to disclose

Presentation(s):

• 578 - Metformin reduces the risk of Long COVID or Death over 6 months in an Emulated Target Trial of Primarily Omicron-infected Adults without Diabetes or Prediabetes: a New-User, Active-Comparator Analysis Using the National COVID Cohort Collaborative (N3C) Electronic Health Record Database. This research was supported in part by the Intramural/Extramural research program of the National Center for Advancing Translational Science, NIH.

  Saturday, October 19, 2024
  2:21 PM – 2:33 PM US PT